comprehensive -WSS

comprehensive

author：explore 2025-10-02 21:07:27 - browse：1687

In 2018, New York University became the first U.S. medical school to go tuition free. Since then, a handful of others have followed with many more considering similar programs. One hope for free tuition endeavors is that lower post-graduation debt will increase the number of med students who choose lower-paying, desperately needed careers in primary care and pediatrics. But free tuition programs are not necessarily delivering on that promise.

In this episode of the First Opinion Podcast, University of Pennsylvania oncologist and researcher Ezekiel Emanuel and Matthew Guido, a project manager in the Healthcare Transformation Institute, discuss their original research on tuition-free programs with former host Pat Skerrett, who is filling in while Torie Bosch is on maternity leave. They make the case that medical school debt is only one of many factors that influence new doctors to choose less-popular specialties and geographic locations for their residencies. Other factors including prestige, the lifetime earning potential of higher-pay specialties, which can add several millions dollars over a career, can have more sway than student debt alone. This is especially important, they say, as needs for patients with chronic illnesses are rapidly outpacing the number of primary care physicians available to give that care.

“We have undervalued both philosophically and also financially the complications of managing chronic illness,” Emanuel says. “Can we rebalance the payment system that rewards the improvements in health and therefore the attention to chronic illness through primary care?”

You can read more about Emanuel and Guido’s opinions in their essay “Free med school tuition won’t solve the shortage of primary care physicians.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

WSS

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Biden warns of ‘dark winter’ during final presidental debate

STAT Report: Patient voices and perspectives

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

6 phony surgeries that take placebo to the extreme

hotspot

comprehensive

knowledge

Activists slam private health insurers over coverage restrictions

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Medicare details structure of new drug price negotiation program

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Psychedelics group wrestles with new pharma identity

With competition flaring, obesity drug hits goal in liver disease study

Jerome Adams on the need for new antivirals for Covid

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Drug repurposing or repositioning? The language matters

In utero gene editing: an explainer

explore

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Alabama hospital puts IVF treatments on hold

The Harvard botanist who searched for psychedelics in the Amazon

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

A new crop of companies is reshaping the health data economy

Former reverend arrested for allegedly killing 8

focus

focus

hotspot

hotspot